cyc 202 has been researched along with Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haylor, J; Khwaja, A; Nutter, F | 1 |
| Liu, B; Preisig, PA | 1 |
2 other study(ies) available for cyc 202 and Hypertrophy
| Article | Year |
|---|---|
Seliciclib inhibits renal hypertrophy but not fibrosis in the rat following subtotal nephrectomy.
Topics: Albuminuria; Animals; Cyclin A1; Cyclin-Dependent Kinase 2; Disease Progression; Extracellular Matrix; Fibrosis; Glomerulosclerosis, Focal Segmental; Hypertension; Hypertrophy; Kidney; Nephrectomy; Purines; Rats; Rats, Wistar; Renal Insufficiency, Chronic; Roscovitine | 2012 |
Compensatory renal hypertrophy is mediated by a cell cycle-dependent mechanism.
Topics: Adaptation, Physiological; Animals; Cell Cycle; Cyclin D; Cyclin E; Cyclins; Enzyme Inhibitors; G1 Phase; Hypertrophy; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Nephrectomy; Protein Kinase Inhibitors; Protein Kinases; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2002 |